Literature DB >> 21499916

Mastocytic enterocolitis as a rare cause of chronic diarrhea in a patient with rheumatoid arthritis.

Rene Thonhofer1, Cornelia Siegel, Markus Trummer, Cord Langner.   

Abstract

The prevalence of chronic diarrhea within the U.S. population has been reported to be as high as five per cent, and numerous causes have been identified. Especially in patients suffering from rheumatoid arthritis drug therapy should be considered as possible cause. We report a case of chronic diarrhea triggered by mastocytic enterocolitis in a patient suffering from rheumatoid arthritis. Systemic mastocytosis and other causes of chronic diarrhea, especially therapy with methotrexate, were carefully ruled out. Treatment with desloratadin and ranitidine was initiated and led to a rapid and persistent amelioration of clinical symptoms. The diagnosis of mastocytic enterocolitis should be considered in patients with chronic diarrhea and normal clinical, laboratory, as well as endoscopical work-up.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499916     DOI: 10.1007/s00508-011-1566-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  8 in total

Review 1.  AGA technical review on the evaluation and management of chronic diarrhea.

Authors:  K D Fine; L R Schiller
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 2.  Enteric neuroimmunophysiology and pathophysiology.

Authors:  Jackie D Wood
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

3.  Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study.

Authors:  J M van Woerkom; A A Kruize; R Geenen; E N van Roon; R Goldschmeding; S M M Verstappen; J A G van Roon; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

4.  Mastocytic enterocolitis: a newly described mast cell entity.

Authors:  Chrishana Ogilvie-McDaniel; Michael Blaiss; F David Osborn; Julie Carpenter
Journal:  Ann Allergy Asthma Immunol       Date:  2008-12       Impact factor: 6.347

5.  Release of mast cell mediators into the jejunum by cold pain stress in humans.

Authors:  J Santos; E Saperas; C Nogueiras; M Mourelle; M Antolín; A Cadahia; J R Malagelada
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

Review 6.  Targeting mast cells in the treatment of functional gastrointestinal disorders.

Authors:  Javier Santos; Carmen Alonso; Mar Guilarte; María Vicario; Juan Ramón Malagelada
Journal:  Curr Opin Pharmacol       Date:  2006-09-07       Impact factor: 5.547

7.  Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.

Authors:  J C Davis; D M van der Heijde; J Braun; M Dougados; D O Clegg; A J Kivitz; R M Fleischmann; R D Inman; L Ni; S-L Lin; W H Tsuji
Journal:  Ann Rheum Dis       Date:  2007-10-29       Impact factor: 19.103

8.  Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea.

Authors:  Shriram Jakate; Mark Demeo; Rohan John; Mary Tobin; Ali Keshavarzian
Journal:  Arch Pathol Lab Med       Date:  2006-03       Impact factor: 5.534

  8 in total
  2 in total

1.  Chronic intractable diarrhea caused by gastrointestinal mastocytosis.

Authors:  Hyungil Seo; Sang Hyoung Park; Jeong-Sik Byeon; Chang Gok Woo; Seung-Mo Hong; Kiju Chang; Hoonsub So; Minseob Kwak; Wan Soo Kim; Jeong-Mi Lee; Dong-Hoon Yang; Kyung-Jo Kim; Byong Duk Ye; Seung-Jae Myung; Suk-Kyun Yang
Journal:  Intest Res       Date:  2016-06-27

2.  Increased Mast Cell Counts and Degranulation in Microscopic Colitis.

Authors:  Zhikai Chi; Jing Xu; Romil Saxena
Journal:  Gastroenterol Res Pract       Date:  2020-01-04       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.